Medtech Industry Veteran joins GelSana as Chief Commercial Officer (AURORA, … Read More
GelSana Featured on 9NEWS
https://www.9news.com/video/news/local/colorado-school-of-mines-professor-creates-gel-to-better-heal-wounds-burns/73-3fe37401-a463-463e-b56a-02db377799e1 We were featured on KUSA-TV, 9NEWS! Proud to see … Read More
GelSana Featured on the Nasdaq tower!
GelSana was featured on the Nasdaq tower in Times Square … Read More
GelSana Selected for Plug and Play Medtech Accelerator
GelSana is thrilled to have been selected to participate in … Read More
GelSana Featured at AdvaMed as a MedTech Innovator 2025 Company
Melissa Krebs presented on a panel at The MedTech Conference … Read More
GelSana Selected for MedTech Innovator 2025 Cohort
We’re In! GelSana Therapeutics, Inc. Joins the 2025 MedTech Innovator … Read More
Melissa Krebs Inducted into the American Institute of Medical and Biological Engineering (AIMBE) College of Fellows
Melissa Krebs, CEO, has been inducted into the American Institute … Read More
GelSana Awarded Another Phase I SBIR from NIDDK
GelSana is proud to announce that we have been awarded … Read More
GelSana Adds Commercialization Expertise with New Board Director, Diana Verrilli
GelSana, an Innosphere Ventures client company, today announced that Diana Verrilli, Chief … Read More
GelSana Hires Chief Operating Officer, Jon Fernandez, to Drive Commercialization and Operations Growth
(AURORA, CO) – May 7, 2024 – GelSana, an Innosphere Ventures … Read More